Why Your Semaglutide or Tirzepatide Results Look Nothing Like Your Friend’s

You started semaglutide the same week your coworker did. Same dose. Same clinic. Three months later, she’s down 22 pounds. You’re down six — and stalled. If you’ve been chasing an explanation for why your semaglutide results look so different from someone else’s, the answer isn’t willpower, portion size, or bad luck. It’s biology. Specifically, it’s three factors that are almost never measured before the first injection — and that quietly determine how well any GLP-1 medication will work in your body.

The GLP-1 Variable Nobody Talks About

GLP-1 medications — semaglutide and tirzepatide — work by mimicking hormones your gut naturally produces to signal fullness, slow digestion, and regulate blood sugar. In a metabolically healthy person, that mechanism fires cleanly. Appetite drops. Blood sugar stabilizes. Fat mobilizes.

But most people starting a GLP-1 medication are not metabolically healthy. That’s the point. And the degree of metabolic dysfunction you’re starting from shapes everything about how the medication performs. Three upstream factors are the most predictive: your baseline insulin resistance, your hormone status, and your gut function. None of them show up on a standard intake form. Most clinics never check them.

What Insulin Resistance Does to Your GLP-1 Response

Insulin resistance is the condition where your cells stop responding normally to insulin — forcing your pancreas to produce more and more of it to move glucose out of the blood. It’s the metabolic root of prediabetes, PCOS, stubborn belly fat, and energy crashes after meals.

Here’s why it matters for GLP-1 weight loss results: semaglutide and tirzepatide improve insulin sensitivity — but if your baseline resistance is severe, the medication spends most of its physiological energy correcting that problem before any meaningful fat loss can begin. You may feel less hungry. You may feel better. But the scale barely moves, and you assume the drug isn’t working.

It is working. It’s just doing triage first.

Patients with moderate insulin resistance often get faster, more dramatic semaglutide results in the early months — because the correction is achievable and the fat loss follows quickly. Patients with severe resistance need a longer runway, and often need additional support (like specific nutritional protocols or targeted supplementation) to make the medication’s job easier. The only way to know where you stand is to run the right labs before you start.

How Hormone Status Shapes What Happens on the Scale

The second major variable is hormone status — and this one disproportionately affects women in their 30s, 40s, and 50s, which is exactly the population most likely to seek medical weight loss in Magnolia TX and surrounding areas.

The Estrogen–GLP-1 Connection

Estrogen plays a direct role in metabolic rate, fat distribution, and how efficiently your body uses energy. As estrogen declines — whether through perimenopause, surgical menopause, or chronic stress — the body tends to shift fat storage toward the abdomen, slow the metabolism, and increase insulin resistance. All three of those changes create headwinds for GLP-1 medications.

This is one reason why two women on identical tirzepatide doses can have completely opposite experiences. The woman in her mid-30s with normal estrogen levels may lose weight relatively smoothly. The woman in perimenopause, with low estrogen and elevated cortisol, may find that her GLP-1 results plateau fast — not because the drug failed, but because the hormonal environment is working against it.

Testosterone, Thyroid, and the Metabolic Brake

Low testosterone in women (yes, women need testosterone too) reduces muscle mass and lowers resting metabolic rate — meaning fewer calories burned at rest, slower progress, and more muscle loss during caloric restriction. Low thyroid function — even subclinical hypothyroidism that doesn’t trigger a standard treatment flag — acts as a metabolic brake that can completely neutralize the benefit of a GLP-1 medication.

If your TSH, free T3, testosterone, or estradiol haven’t been checked recently and interpreted in the context of weight loss — not just in isolation — you don’t have a complete picture of why your results are what they are.

At Made Ya Skinny, patients who aren’t getting the semaglutide results they expected often discover a hormone imbalance they didn’t know they had. That’s why our physician-supervised GLP-1 weight loss program includes hormone evaluation alongside medication management — because treating the medication in isolation misses the point.

Gut Function: The Invisible Factor in Medication Response

The third variable is gut function, and it’s the most overlooked of all.

GLP-1 receptors are concentrated in the gut. The gut microbiome directly influences how GLP-1 signals are produced and received. A disrupted microbiome — from years of processed food, antibiotic use, chronic stress, or low-grade gut inflammation — can blunt the medication’s effect even when everything else looks fine on paper.

Beyond the microbiome, gut motility matters. Tirzepatide and semaglutide slow gastric emptying — that’s part of how they reduce appetite. But if you already have sluggish gut motility from IBS, hypothyroidism, or years of low-fiber eating, the medication can cause significant GI distress without proportional benefit. Patients in this situation often reduce or stop their dose prematurely, concluding that the drug doesn’t agree with them — when the real issue is an underlying gut problem that needed to be addressed first.

Why These Three Factors Compound Each Other

Insulin resistance, hormone imbalance, and poor gut function don’t operate in isolation. They feed each other.

Estrogen decline worsens insulin resistance. Insulin resistance drives cortisol up, which further suppresses thyroid function. Chronic cortisol elevation disrupts the gut microbiome. A disrupted microbiome impairs nutrient absorption, which can cause deficiencies in magnesium, B12, and zinc — all of which are required for normal insulin signaling.

This is why the person who seems to “fail” on GLP-1 medications is often dealing with a cascade, not a single problem. A drug that treats one piece of that cascade without addressing the rest produces partial results at best. This is also why why GLP-1 stopped working is rarely a question with a simple answer — and rarely a reason to simply increase the dose.

What to Do When GLP-1 Isn’t Working the Way You Expected

If you’re on semaglutide or tirzepatide and your results have stalled, slowed, or never matched what you expected — the answer is almost always in the blood work.

Standard lab panels don’t catch what matters here. A fasting insulin level (not just glucose). A full thyroid panel including free T3 and reverse T3. Sex hormones measured at the right point in the cycle. Inflammatory markers. Nutrient status. These are the labs that explain the gap between what the medication should do and what it’s actually doing in your specific body.

When GLP-1 stops working or weight comes back, the answer is often in the blood work. Made Ya Skinny takes a functional medicine approach — running the right labs, reading them correctly, and building a plan around what your body actually needs rather than just increasing the dose. Whether that means addressing hormone deficiency with bioidentical hormone replacement therapy, correcting a nutrient gap that’s blocking insulin signaling, or adjusting the medication protocol based on what the labs show — the goal is to make the medication work for your biology, not fight against it.

That’s what separates a weight loss clinic near me that just writes prescriptions from one that actually works to understand why your results are what they are.

Frequently Asked Questions

Why do semaglutide results vary so much from person to person?

Semaglutide results are heavily influenced by baseline metabolic health — specifically insulin resistance, hormone status, and gut function. Two people on the same dose can have dramatically different outcomes because the medication’s effectiveness depends on the physiological environment it’s working in. A thorough lab evaluation before or during treatment helps identify which factors are limiting your response.

What does it mean if tirzepatide stopped working?

A tirzepatide plateau usually signals that the medication has corrected what it can correct without additional support. The most common causes are untreated insulin resistance, hormone imbalance (especially declining estrogen or testosterone), thyroid dysfunction, or nutritional deficiencies that impair metabolic signaling. These are lab-findable, correctable problems — not a sign that you need a higher dose or a different drug.

Can hormone imbalance cause a GLP-1 plateau?

Yes. Low estrogen, low testosterone, and subclinical hypothyroidism all reduce metabolic rate and increase insulin resistance — both of which limit how effectively GLP-1 medications can drive fat loss. Many patients who plateau on semaglutide or tirzepatide discover a correctable hormone imbalance when they run a proper panel. Addressing it with bioidentical hormone replacement therapy often restores progress.

What labs should be checked before starting or during GLP-1 therapy?

At minimum: fasting insulin (not just glucose), full thyroid panel (TSH, free T3, free T4, reverse T3), sex hormones (estradiol, testosterone, DHEA-S), a comprehensive metabolic panel, inflammatory markers like CRP, and key nutrient levels including magnesium, B12, and vitamin D. These are the markers that explain why results diverge between patients on identical protocols.

Is telehealth available for GLP-1 weight loss and hormone evaluation?

Yes. Made Ya Skinny offers telehealth consultations for patients across multiple states, making physician-supervised GLP-1 management and functional lab review accessible beyond the Magnolia, TX area. Local patients in Cypress, The Woodlands, Conroe, Willis, Montgomery, Tomball, and North Houston can be seen in person.

Ready to Find Out What’s Actually Driving Your Results?

Your semaglutide or tirzepatide results aren’t random. They’re the output of a specific metabolic environment — one that can be measured, understood, and corrected. If your weight loss has stalled, slowed, or never matched your expectations, the next step isn’t guessing. It’s getting the right information.

Made Ya Skinny’s physician-supervised approach combines GLP-1 medication management with functional lab review, hormone evaluation, and personalized protocols built around your actual biology — not a one-size-fits-all prescription. Book your $17 visit and find out exactly what’s standing between you and the results you came for.